These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28646245)

  • 1. Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study.
    Gadre A; Ghattas C; Han X; Wang X; Minai O; Highland KB
    Lung; 2017 Oct; 195(5):529-536. PubMed ID: 28646245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.
    Vandecasteele E; De Pauw M; De Keyser F; Decuman S; Deschepper E; Piette Y; Brusselle G; Smith V
    Int J Cardiol; 2016 Jun; 212():265-73. PubMed ID: 27057932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.
    Villalba WO; Sampaio-Barros PD; Pereira MC; Cerqueira EM; Leme CA; Marques-Neto JF; Paschoal IA
    Chest; 2007 Jan; 131(1):217-22. PubMed ID: 17218579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis.
    Lefèvre G; Dauchet L; Hachulla E; Montani D; Sobanski V; Lambert M; Hatron PY; Humbert M; Launay D
    Arthritis Rheum; 2013 Sep; 65(9):2412-23. PubMed ID: 23740572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension.
    Codullo V; Caporali R; Cuomo G; Ghio S; D'Alto M; Fusetti C; Borgogno E; Montecucco C; Valentini G
    Arthritis Rheum; 2013 Sep; 65(9):2403-11. PubMed ID: 23754201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension.
    Lui JK; Gillmeyer KR; Sangani RA; Smyth RJ; Gopal DM; Trojanowski MA; Bujor AM; Soylemez Wiener R; LaValley MP; Klings ES
    Lung; 2023 Dec; 201(6):565-569. PubMed ID: 37957388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension.
    Lui JK; Cozzolino M; Winburn M; Trojanowski MA; Wiener RS; LaValley MP; Bujor AM; Gopal DM; Klings ES
    Chest; 2024 Jun; 165(6):1505-1517. PubMed ID: 38128607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.
    Valerio CJ; Schreiber BE; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheum; 2013 Apr; 65(4):1074-84. PubMed ID: 23280155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort.
    Lammi MR; Saketkoo LA; Gordon JK; Lauto P; Fagan K; Steen VD;
    Respirology; 2017 Oct; 22(7):1386-1392. PubMed ID: 28500695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.
    Sanges S; Launay D; Rhee RL; Sitbon O; Hachulla É; Mouthon L; Guillevin L; Rottat L; Montani D; De Groote P; Cottin V; Magro P; Prévot G; Bauer F; Bergot E; Chabanne C; Reynaud-Gaubert M; Leroy S; Canuet M; Sanchez O; Gut-Gobert C; Dauphin C; Pison C; Boissin C; Habib G; Clerson P; Conesa F; Cordier JF; Kawut SM; Simonneau G; Humbert M
    Ann Rheum Dis; 2016 Aug; 75(8):1457-65. PubMed ID: 26324844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-minute walk test in or out in evaluation of systemic sclerosis patients?
    Vandecasteele E; Thevissen K; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Brusselle G; Smith V
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):122-129. PubMed ID: 28229829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
    Choi JH; Joo SJ; Kim J
    Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis.
    Pugnet G; Marjanovic Z; Deligny C; Boussardon K; Benzidia I; Puyade M; Lansiaux P; Vandecasteele E; Smith V; Farge D
    J Rheumatol; 2018 Aug; 45(9):1273-1280. PubMed ID: 29961695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.
    Bernstein EJ; Gordon JK; Spiera RF; Huang WT; Horn EM; Mandl LA
    Rheumatology (Oxford); 2017 Jan; 56(1):87-94. PubMed ID: 28028158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with the 6-minute walk distance in patients with systemic sclerosis.
    Sanges S; Giovannelli J; Sobanski V; Morell-Dubois S; Maillard H; Lambert M; Podevin C; Lamblin N; De Groote P; Bervar JF; Perez T; Matran R; Rémy-Jardin M; Hatron PY; Hachulla É; Launay D
    Arthritis Res Ther; 2017 Dec; 19(1):279. PubMed ID: 29246248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.